CTVA Quote, Financials, Valuation and Earnings

Celanese has a net margin of -1.03% compared to Corteva's net margin of -80.76%. Corteva's return on equity of 3.64% beat Celanese's return on equity of -21.13%.

Corteva has a consensus price target of $69.21, signalling upside risk potential of 15.7%. On the other hand Celanese has an analysts' consensus of $65.50 which suggests that it could grow by 14.81%. Given that Corteva has higher upside potential than Celanese, analysts believe Corteva is more attractive than Celanese.

Corteva has a beta of 0.789, which suggesting that the stock is 21.086% less volatile than S&P 500. In comparison Celanese has a beta of 1.227, suggesting its more volatile than the S&P 500 by 22.728%.

Corteva has a quarterly dividend of $0.17 per share corresponding to a yield of 1.12%. Celanese offers a yield of 3.73% to investors and pays a quarterly dividend of $0.03 per share. Corteva pays 50.5% of its earnings as a dividend. Celanese pays out -20.17% of its earnings as a dividend. Corteva's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Corteva quarterly revenues are $4B, which are larger than Celanese quarterly revenues of $2.4B. Corteva's net income of -$41M is higher than Celanese's net income of -$1.9B. Notably, Corteva's price-to-earnings ratio is 46.37x while Celanese's PE ratio is 7.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Corteva is 2.46x versus 0.61x for Celanese. Usually stocks with elevated PS ratios are considered overvalued.

Dow has a net margin of -1.03% compared to Corteva's net margin of -0.51%. Corteva's return on equity of 3.64% beat Dow's return on equity of 5.97%.

Corteva has a consensus price target of $69.21, signalling upside risk potential of 15.7%. On the other hand Dow has an analysts' consensus of $45.18 which suggests that it could grow by 22.2%. Given that Dow has higher upside potential than Corteva, analysts believe Dow is more attractive than Corteva.

Corteva has a beta of 0.789, which suggesting that the stock is 21.086% less volatile than S&P 500. In comparison Dow has a beta of 1.180, suggesting its more volatile than the S&P 500 by 17.993%.

Corteva has a quarterly dividend of $0.17 per share corresponding to a yield of 1.12%. Dow offers a yield of 7.57% to investors and pays a quarterly dividend of $0.70 per share. Corteva pays 50.5% of its earnings as a dividend. Dow pays out 176.17% of its earnings as a dividend. Corteva's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Dow's is not.

Corteva quarterly revenues are $4B, which are smaller than Dow quarterly revenues of $10.4B. Corteva's net income of -$41M is higher than Dow's net income of -$53M. Notably, Corteva's price-to-earnings ratio is 46.37x while Dow's PE ratio is 23.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Corteva is 2.46x versus 0.61x for Dow. Usually stocks with elevated PS ratios are considered overvalued.

Nucor has a net margin of -1.03% compared to Corteva's net margin of 4.06%. Corteva's return on equity of 3.64% beat Nucor's return on equity of 9.33%.

Corteva has a consensus price target of $69.21, signalling upside risk potential of 15.7%. On the other hand Nucor has an analysts' consensus of $155.62 which suggests that it could grow by 17.82%. Given that Nucor has higher upside potential than Corteva, analysts believe Nucor is more attractive than Corteva.

Corteva has a beta of 0.789, which suggesting that the stock is 21.086% less volatile than S&P 500. In comparison Nucor has a beta of 1.578, suggesting its more volatile than the S&P 500 by 57.84%.

Corteva has a quarterly dividend of $0.17 per share corresponding to a yield of 1.12%. Nucor offers a yield of 1.64% to investors and pays a quarterly dividend of $0.55 per share. Corteva pays 50.5% of its earnings as a dividend. Nucor pays out 25.75% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Corteva quarterly revenues are $4B, which are smaller than Nucor quarterly revenues of $7.1B. Corteva's net income of -$41M is lower than Nucor's net income of $287M. Notably, Corteva's price-to-earnings ratio is 46.37x while Nucor's PE ratio is 15.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Corteva is 2.46x versus 1.03x for Nucor. Usually stocks with elevated PS ratios are considered overvalued.

Paramount Gold Nevada has a net margin of -1.03% compared to Corteva's net margin of --. Corteva's return on equity of 3.64% beat Paramount Gold Nevada's return on equity of --.

Corteva has a consensus price target of $69.21, signalling upside risk potential of 15.7%. On the other hand Paramount Gold Nevada has an analysts' consensus of -- which suggests that it could grow by 216.62%. Given that Paramount Gold Nevada has higher upside potential than Corteva, analysts believe Paramount Gold Nevada is more attractive than Corteva.

Corteva has a beta of 0.789, which suggesting that the stock is 21.086% less volatile than S&P 500. In comparison Paramount Gold Nevada has a beta of 1.923, suggesting its more volatile than the S&P 500 by 92.323%.

Corteva has a quarterly dividend of $0.17 per share corresponding to a yield of 1.12%. Paramount Gold Nevada offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Corteva pays 50.5% of its earnings as a dividend. Paramount Gold Nevada pays out -- of its earnings as a dividend. Corteva's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Corteva quarterly revenues are $4B, which are larger than Paramount Gold Nevada quarterly revenues of --. Corteva's net income of -$41M is lower than Paramount Gold Nevada's net income of -$2M. Notably, Corteva's price-to-earnings ratio is 46.37x while Paramount Gold Nevada's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Corteva is 2.46x versus -- for Paramount Gold Nevada. Usually stocks with elevated PS ratios are considered overvalued.